Cathie Wood’s ARK Invest Posts Fund Purchases For Monday, Dec. 13, 2021: SYSS, NTLA, DNA, PD, BLI, CRSP, MTLS, NVTA, VUZI, BLDE, ROKU, COIN, EDR, ONEM, SDGR, ACCD, SLGC, MASS, QSI, PSNL, PATH, TOST, HOOD, SE, NU, KTOS, AVAV
STRATASYS LTD (SSYS) - 78600
INTELLIA THERAPEUTICS INC (NTLA) - 16800
GINKGO BIOWORKS HOLDINGS INC (DNA) - 130745
PAGERDUTY INC (PD) - 24394
BERKELEY LIGHTS INC (BLI) - 29549
CRISPR THERAPEUTICS AG (CRSP) -
Goldman Sachs Maintains Neutral on Toast, Lowers Price Target to $44
Goldman Sachs maintains Toast (NYSE:TOST) with a Neutral and lowers the price target from $59 to $44.
Where Toast Stands With Analysts
Analysts have provided the following ratings for Toast (NYSE:TOST) within the last quarter:
Northcoast Research Initiates Coverage On Toast with Neutral Rating
Northcoast Research analyst Kartik Mehta initiates coverage on Toast (NYSE:TOST) with a Neutral rating.
Cathie Wood’s ARK Invest Posts Fund Purchases For Monday, Nov. 15, 2021: NTLA, TWOU, VCYT, BEAM, MTLS, PRLB, TSP, ACHR, VLD, SPLK, DIS, BFLY, SGFY, ONEM, ALLO, VERV, QSI, HOOD, DKNG, TWLO, TOST, PAG, GRMN, DDD, MKFG
Intellia Therapeutics (NTLA)
2U (TWOU)
Veracyte (VCYT)
Beam Therapeutics (BEAM)
Materialise (MTLS)
Proto Labs (PRLB)
TuSimple Holdings (TSP)
Archer Aviation (ACHR)
Velo3d (VLD)
Splunk (SPLK)
The Walt Disney
76 Biggest Movers From Yesterday
Gainers
Expensify, Inc. (NASDAQ: EXFY) jumped 52.1% to settle at $41.06 on Wednesday after the company priced its IPO at $27 per share.
Expert Ratings For Toast
Analysts have provided the following ratings for Toast (NYSE:TOST) within the last quarter:
55 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
RenovoRx, Inc. (NASDAQ: RNXT) shares jumped 128% to $12.41. The company, on Tuesday evening, made a presentation on intra-arterial chemotherapy as a potential innovative treatment for pancreatic cancer.